Precision Pharmacy and Wickliffe Veterinary Pharmacy announced that the two leading equine compounding providers have finalized a merger agreement, creating the country’s largest equine-focused compounding pharmacy group. Wickliffe and Precision Pharmacy offer equine veterinarians expert service and quality products backed by an elite team of pharmacy professionals. With over 40 years of combined industry experience, the two businesses expect that the merger will enable additional investments in research and development, such as upgrades to their technology offerings to enable customers to better navigate a changing regulatory environment.
“Our merger with Precision Pharmacy accelerates and expands our ability to offer veterinarians the increasingly specialized pharmaceutical services they need” says Jackie Bernard, Founder of Wickliffe Pharmaceuticals. “Precision Pharmacy has built a reputation for operating an outstanding quality, testing and research program. We’re thrilled to expand our team with like-minded professionals to ensure our customers receive the highest-quality products.”
The new combined entity anticipates a significant improvement in meeting veterinarian needs as the regulatory environment shifts with the expected April launch of the FDA’s GFI 256 guidance.
“The Wickliffe team has been on the cutting edge of pharmacy technology in recent years” said Patrick Wade, Founder of Precision Pharmacy. “The digitization of their pharmacy enables them to serve their customers quickly, while simultaneously increasing the quality and safety of their compounds. We are excited to bring this technology to our facility, and are looking forward to launching additional solutions to our customers as a combined company in early 2023.”